Physician profile
Christopher D Miller
NPI 1699777409
$6,668.97
in general payments reported to CMS, 2019-2025
38 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $459 · 2021: $1,147 · 2022: $972 · 2023: $722 · 2024: $937 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,640 · Travel and Lodging: $59.00 · Education: $27.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,640.13 |
| Travel and Lodging | $59.00 |
| Education | $27.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,306.49 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,101.60 | 2019-2025 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $491.96 | 2019-2023 | Entyvio |
| Janssen Biotech, INC. | $441.80 | 2019-2025 | Tremfya, Stelara |
| Ipsen Biopharmaceuticals, INC | $325.87 | 2024-2025 | Iqirvo |
| Pfizer INC. | $232.65 | 2019-2025 | |
| Qol Medical, LLC | $202.46 | 2019-2024 | Sucraid, Sucraid |
| Genzyme Corporation | $196.25 | 2022-2025 | |
| Intuitive Surgical, INC. | $181.38 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $115.38 | 2022-2024 | Dupixent |
| Medical Device Business Services, INC. | $114.84 | 2019 | |
| Aimmune Therapeutics, INC. | $102.97 | 2024-2025 | Zenpep, Vowst |
| Lilly USA, LLC | $102.74 | 2024 | Omvoh |
| Merck Sharp & Dohme LLC | $96.42 | 2019-2023 | Dificid |
| Intercept Pharmaceuticals, INC. | $82.60 | 2019-2025 | Ocaliva |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.